Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Okyanos Center for Regenerative Medicine, also known as Okyanos Global Health, was a specialized healthcare facility located in Freeport, Bahamas, that focused on adult stem cell therapy. The center primarily utilized adipose-derived regenerative cells (ADRCs) to treat patients with chronic, degenerative conditions such as cardiovascular disease, orthopedic issues, and autoimmune disorders. Using the Cytori Celution System, Okyanos isolated a patient's own stem cells from fat tissue for immediate, same-day treatment. The facility operated under the oversight of the Bahamas National Stem Cell Ethics Committee and was a key player in the medical tourism sector for regenerative medicine. Despite its prominence, the center reportedly ceased operations around 2021.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Okyanos Global Health.